Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Bat biotech takes flight

Nature Biotechnology volume 41, pages 1047–1052 (2023)Cite this article

Harnessing the unusual biology of bats, researchers aim to turn drug discovery upside-down.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Bat iPS cells.

Courtesy Phil Ferro, Paratus Sciences

Fig. 2: Bats have evolved a reduced inflammation response to cytosolic DNA, a byproduct of flight.

Author information

Authors and Affiliations

  1. Somerville, MA, USA

    Elie Dolgin

Authors
  1. Elie Dolgin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolgin, E. Bat biotech takes flight. Nat Biotechnol 41, 1047–1052 (2023). https://doi.org/10.1038/s41587-023-01880-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-023-01880-y

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing